← Every company
Sunshine Biopharma Inc SEC Filings
What Sunshine Biopharma Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
SBFM overview →Filings on file
129
since Nov 14, 2016
Warning signs
23
latest Mar 31, 2026
Last results
Apr 9, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Aug 28, 2026 | Executive or director change 8-K | Read ↗ |
| Feb 5, 2026 | Executive or director change 8-K | Read ↗ |
| Jan 15, 2025 | Executive or director change 8-K | Read ↗ |
| Oct 23, 2024 | Executive or director change 8-K | Read ↗ |
| Jan 30, 2024 | Executive or director change 8-K | Read ↗ |
| Oct 20, 2022 | Executive or director changeAcquisition or sale completedMaterial agreementUnregistered share sale 8-K | Read ↗ |
| Apr 8, 2022 | Executive or director change 8-K | Read ↗ |
| Nov 3, 2021 | Executive or director change 8-K | Read ↗ |
Source: Sunshine Biopharma Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.